Journal of Advanced Biotechnology and Experimental Therapeutics (JABET) – is an open-access, international, peer-reviewed, scientific journal publishing original research findings and reviews on all aspects of biotechnology and experimental therapeutics. It provides a platform for Scientists and Academicians all over the world to promote, share, and discuss various new issues and developments in translational research and recent discoveries in the Biotechnology and Biomedical Sciences.
🌀 Short name: J Adv Biotechnol Exp Ther
🌀 Electronic ISSN: 2616-4760
🌀 Year of starting: September 2017, first issue- January 2018
🌀The frequency of publication: 3 times a year (January, May, and September) in the English language. We also offer special issues on emerging topics. However, accepted papers will be published continuously in the journal (as soon as accepted).
🌀 License type: Free for non-commercial use (CC-BY-NC 4.0), [OPEN ACCESS]
🌀 DOI: Available for each article
🌀 Country of publication: South Korea
🌀 Publisher: Bangladesh Society for Microbiology, Immunology, and Advanced Biotechnology
🌀 The scope of publication: JABET is devoted to publishing the latest developments in translational research and the recent discoveries in the field of Biotechnology and Biomedical Sciences. Submission is encouraged of papers that involve genetic, molecular, and cellular studies of human, animal, environment, and plant subjects. Papers should provide rigorous quantitative analyses and/or new insights on biochemical mechanisms.
🌀 The vision of the journal:
The vision of our journal is to
👉Upgrade the awareness among experts and young scientists about modern breakthroughs and emerging opportunities in biotechnology and Biomedical research.
👉Establish rapid peer review processes to accelerate the publication of excellent research papers of their interest.
👉Meet the vigorously increasing demand for essential biotechnological and medical information by disseminating significant advances and grand results of scientific works and discoveries to the broader global health community.
👉Assist in the dissemination of journal content to the global arena.
👉Contribute to publishing high-quality research data for the improvement of the overall livelihood of the world population.
👉Aid scientists and global audience through prompt publication of rigorous peer-reviewed articles.
The open-access journal supports the open exchange of advanced scientific information among scientists and upcoming researchers. Our journal ensures that its access policies and practices for information dissemination are consistent with the sustainability of a system requiring careful scientific review prior to publication.
🌀 Editorial Office
Journal of Advanced Biotechnology and Experimental Therapeutics
4-7, Nogosan-dong, Mapogu
Seoul, South Korea.
Email: firstname.lastname@example.org or email@example.com